AzTrials
AzTrials

Post Partum DepressionHUGSNCT05209789

Early Intervention to Protect the Mother-Child Relationship After Postpartum Depression

A study testing HUGS and Playtime in people with Post Partum Depression, run by University Hospital, Toulouse at 7 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Postpartum depression (PPD) may impair the mother-infant relationship and lead to both short and long-term suboptimal development of the baby. This study aims to evaluate the effectiveness of a targeted intervention (HUGS: Happiness Understanding Giving and Sharing) for enhancing the mother-infant relationship. Read more about this study

Who is it for?
Ages 18 to 100 years, women only
Conditions the study is for
Post Partum Depression
What is being tested?
HUGS and Playtime
Could I receive a placebo?
No, everyone receives an active treatment
How many people
104 participants
Where
7 sitesFrance
Study dates
18 Dec 2023to 25 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Person affiliated or beneficiary of a social security plan;
  • Free, informed and written consent signed by the participant and the investigator (at the latest on the day of inclusion and before any examination required by the research);
  • Woman who gave birth in one of the maternity hospitals participating in the study;
  • Diagnosis of postpartum depression made by the perinatal psychiatry team according to the clinical criteria of the DSM-5;
  • Time to onset of depressive symptoms within the first 12 months after childbirth;
  • Treatment for postpartum depression that started at least 8 weeks ago with improved mood as assessed by the psychiatrist.
Show all 16Show fewer
  • Baby aged less than 1 year at inclusion;
  • Twins will be able to participate in the study and benefit from the interventions;
  • Non-inclusion criteria concerning the mother:
  • Uncontrolled substance use disorder;
  • Presence of suicidal ideas at inclusion;
  • Manic episode of a bipolar disease
  • Psychiatric pathology decompensated upon inclusion and corresponding to the following list: Schizophrenic disorder, Schizoaffective disorder, Mood disorders with psychotic symptoms;
  • Non French speaker.
  • Non-inclusion criteria for the baby:
  • Baby hospitalized or having sustained medical care upon inclusion in the context of a somatic pathology.

Who cannot join

None listed.

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

France7 sites
  • Bordeaux Public Hospital

    Bordeaux

  • Havre Public Hospital Maternity

    Le Havre

  • Reims Public Hospital Maternity

    Reims

  • Rouen Public Hospital Maternity

    Rouen

  • Toulouse Child Guidance

    Toulouse

  • Toulouse Joseph Ducuing Maternity

    Toulouse

  • Toulouse Public Hospital Maternity

    Toulouse

Other trials in France

About this study

Official title: HUGS : Early Intervention to Protect the Mother-Child Relationship After Postpartum Depression: A Randomized Comparative Trial of the Cognitive Behavioral Therapy Program

Postpartum depression (PPD) may impair the mother-infant relationship and lead to both short and long-term suboptimal development of the baby. This study aims to evaluate the effectiveness of a targeted intervention (HUGS: Happiness Understanding Giving and Sharing) for enhancing the mother-infant relationship.

Read the detailed description

Post-partum depression (PPD) is the most common psychological pathology following childbirth and affects 12% of women in France. This pathology may impair the mother-infant relationship and lead to suboptimal development of the baby in the short and long-term. The prevalence of early interaction disorders is estimated at 73% among women suffering from PPD. Although treatments for PDD are effective, the mother-infant interaction remains impaired, as well as the short, medium and long-term development of the child. It is therefore essential to develop at a very early stage an intervention specifically targeting the mother-infant interaction, and to integrate this care into the general care given to mothers suffering from PPD.

A short cognitive-behavioural therapy intervention focused on improving the quality of the mother-infant relationship (the HUGS program: Happiness, Understanding, Giving and Sharing) has been created and validated by Prof. Jeannette Milgrom's Australian team. The objective of our study is to evaluate the effectiveness of the HUGS programme compared to a Playtime control group using a randomised controlled trial in a population of women suffering from PPD and being cared for in 7 French maternity hospitals. The comparison will be made 6 months after intervention initiation using "Factor 1: Mother Positive Affective Involvement and Verbalization" of the PCERA (Parent-Child Early Relational Assessment) mother-child interaction evaluation scale.

Being tested
HUGS, Playtime
Keywords
Mother-baby interaction, Group therapy, Cognitive behavioral therapy, mother-infant relationship
Medical subject headings
Depression, Postpartum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HUGSBehavioural

    Group therapy with the participation of two therapist positively encouraging mother-baby interactions in a non-judgmental manner

  • PlaytimeBehavioural

    Very little intervention from the therapists

Study groups in NCT05209789
Study groupRoleWhat they receive
HUGS therapyExperimentalA structured group intervention that aims to observe mother's behavior and responses with her baby, promote mother-baby interaction through play, and provide tools for positive interaction. This therapy involves cognitive and behavioral work. Therapists observe the mother-baby duo and share their observations from a perspective of encouragement and support. A playful and non-judgmental interaction is cultivated within the group. The main objective is to change the negative trajectory of mother-child interactions through tools from cognitive-behavioral therapies as well as using knowledge about child development.
Receives: Behavioral: HUGS
PlaytimeActive comparatorThe participants assigned to the control group will also be in the presence of two therapists, allowing to reproduce the framework of the HUGS therapy. The difference will be the lack of direct therapeutic intervention from the therapists, but only classic psychoeducational guidance. The mothers are offered a time to play with their baby as well as the opportunity to discuss and share their experiences with other mothers, which is generally seen as supportive by them.
Receives: Behavioral: Playtime

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mother-infant interaction

    The primary endpoint will be the score of factor 1 ("positive affective commitment of the mother as well as her verbalization skills with her baby") of the mother-baby interaction assessment scale The Parent-Child Early Relational Assessment ( PCERA) between the two study groups : HUGS and Playtime.

    PCERA factor 1 will be measured by analysis of video footage of each mother-baby duo by two independent blind assessors from allocation groups.The score taken into account will be the consensus score between the two evaluators.

    Measured: 6 months after the end of the intervention

Secondary outcomes (3)
  1. Mothers' stress

    Parental Stress Index (PSI-3) measured on both groups. This index is categorised in various items (stressors), each including a Likert style index from 1 to 5. The PSI-3 sums up all the items into a score : a high score representing a high stress for the parent.

    Measured: Right before the intervention (Baseline)

  2. Mothers' stress

    Parental Stress Index (PSI-3) measured on both groups. This index is categorised in various items (stressors), each including a Likert style index from 1 to 5. The PSI-3 sums up all the items into a score : a high score representing a high stress for the parent.

    Measured: Right at the end of the intervention : 28 days after the start of the study

  3. Mothers' stress

    Parental Stress Index (PSI-3) measured on both groups. This index is categorised in various items (stressors), each including a Likert style index from 1 to 5. The PSI-3 sums up all the items into a score : a high score representing a high stress for the parent.

    Measured: 6 months after the end of the intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2022
  2. Study start18 Dec 2023
  3. Primary completion25 Mar 2026
  4. Study completion25 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Multicenter, interregional, comparative, prospective therapeutic study in 2 parallel groups (1: 1), superiority, randomized, blinded for the evaluation of the primary endpoint.
Masking
Single blind
Who is masked
Participant
Enrolment
104 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05209789
Sponsor's protocol ID
RC31/21/0166
Acronym
HUGS
Status last verified
May 2026
First submitted
11 Jan 2022
Last updated
12 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing HUGS and Playtime in people with Post Partum Depression, run by University Hospital, Toulouse at 7 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 16 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mother-infant interaction (time frame: 6 months after the end of the intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in